spacer gif spacer gif spacer gif spacer gif Propose a workshop for 2011 spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search    

The fully linked HTML version of this article has now been published.
JCS ePress online publication date 20 Jan 2004
doi: 10.1242/jcs.00898

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.00898v1
117/5/677    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De la Vieja, A.
Right arrow Articles by Carrasco, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De la Vieja, A.
Right arrow Articles by Carrasco, N.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Article

The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number


Antonio De la Vieja, Christopher S. Ginter, and Nancy Carrasco*
* Author for correspondence (e-mail: carrasco{at}aecom.yu.edu)

The Na+/I- symporter (NIS) is a key plasma membrane glycoprotein that mediates active iodide (I-) transport in the thyroid and other tissues. Since isolation of the cDNA encoding NIS (G. Dai, O. Levy, and N. Carrasco (1996) Nature 379, 458-460), ten mutations in NIS have been identified as causes of congenital iodide transport defect (ITD). Two of these mutations (T354P and G395R) have been thoroughly characterized at the molecular level. Both mutant NIS proteins are inactive but normally expressed and correctly targeted to the plasma membrane. The hydroxyl group at the {beta}-carbon of residue 354 is essential for NIS function, whereas the presence of a charged or large side-chain at position 395 interferes with NIS function. We report the extensive molecular analysis of the Q267E mutation in COS-7 cells transfected with rat or human Q267E NIS cDNA constructs. We used site-directed mutagenesis to engineer various residue substitutions into position 267. In contrast to previous suggestions that Q267E NIS was inactive, possibly because of a trafficking defect, we conclusively show that Q267E NIS is modestly active and properly targeted to the plasma membrane. Q267E NIS exhibited lower Vmax values for I- than wild-type NIS, suggesting that the decreased level of activity of Q267E NIS is due to a lower catalytic rate. That Q267E NIS retains even partial activity sets this ITD-causing mutant apart from T354P and G395R NIS. The presence of charged residues (of any polarity) other than Glu at position 267 rendered NIS inactive without affecting its expression or targeting, but substitution with neutral residues at this position was compatible with partial activity.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
G. Riesco-Eizaguirre, I. Rodriguez, A. De la Vieja, E. Costamagna, N. Carrasco, M. Nistal, and P. Santisteban
The BRAFV600E Oncogene Induces Transforming Growth Factor {beta} Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer
Cancer Res., November 1, 2009; 69(21): 8317 - 8325.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
V. E. Smith, M. L. Read, A. S. Turnell, R. J. Watkins, J. C. Watkinson, G. D. Lewy, J. C. W. Fong, S. R. James, M. C. Eggo, K. Boelaert, et al.
A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer
J. Cell Sci., September 15, 2009; 122(18): 3393 - 3402.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Bizhanova and P. Kopp
The Sodium-Iodide Symporter NIS and Pendrin in Iodide Homeostasis of the Thyroid
Endocrinology, March 1, 2009; 150(3): 1084 - 1090.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
S.-L. Wu, T.-Y. Ho, J.-A. Liang, and C.-Y. Hsiang
Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter
J. Endocrinol., November 1, 2008; 199(2): 213 - 219.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. D. Reed-Tsur, A. De la Vieja, C. S. Ginter, and N. Carrasco
Molecular Characterization of V59E NIS, a Na+/I- Symporter Mutant that Causes Congenital I- Transport Defect
Endocrinology, June 1, 2008; 149(6): 3077 - 3084.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. Dayem, C. Basquin, V. Navarro, P. Carrier, R. Marsault, P. Chang, S. Huc, E. Darrouzet, S. Lindenthal, and T. Pourcher
Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization
J. Endocrinol., April 1, 2008; 197(1): 95 - 109.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. D. Vadysirisack, E. S.-W. Chen, Z. Zhang, M.-D. Tsai, G.-D. Chang, and S. M. Jhiang
Identification of in Vivo Phosphorylation Sites and Their Functional Significance in the Sodium Iodide Symporter
J. Biol. Chem., December 21, 2007; 282(51): 36820 - 36828.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. De la Vieja, M. D. Reed, C. S. Ginter, and N. Carrasco
Amino Acid Residues in Transmembrane Segment IX of the Na+/I Symporter Play a Role in Its Na+ Dependence and Are Critical for Transport Activity
J. Biol. Chem., August 31, 2007; 282(35): 25290 - 25298.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
G. Riesco-Eizaguirre and P. Santisteban
A perspective view of sodium iodide symporter research and its clinical implications.
Eur. J. Endocrinol., October 1, 2006; 155(4): 495 - 512.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Paroder, S. R. Spencer, M. Paroder, D. Arango, S. Schwartz Jr., J. M. Mariadason, L. H. Augenlicht, S. Eskandari, and N. Carrasco
Na+/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: Molecular characterization of SMCT
PNAS, May 9, 2006; 103(19): 7270 - 7275.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Szinnai, S. Kosugi, C. Derrien, N. Lucidarme, V. David, P. Czernichow, and M. Polak
Extending the Clinical Heterogeneity of Iodide Transport Defect (ITD): A Novel Mutation R124H of the Sodium/Iodide Symporter Gene and Review of Genotype-Phenotype Correlations in ITD
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1199 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. De la Vieja, C. S. Ginter, and N. Carrasco
Molecular Analysis of a Congenital Iodide Transport Defect: G543E Impairs Maturation and Trafficking of the Na+/I- Symporter
Mol. Endocrinol., November 1, 2005; 19(11): 2847 - 2858.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Z. Zhang, Y.-Y. Liu, and S. M. Jhiang
Cell Surface Targeting Accounts for the Difference in Iodide Uptake Activity between Human Na+/I- Symporter and Rat Na+/I- Symporter
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6131 - 6140.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2004